Founded in 2009, A Plus Biotechnology Corporation Limited is a leading supplier of orthopedic medical solutions, concentrating on designing, developing, and manufacturing orthopedic implants and patient-specific instruments (PSI). It specialises in anatomical locking plates, high tibial osteotomy (HTO) systems, and biologics adapted to Asian bone structures, serving orthopedics and regenerative medicine. By collaborating with academic and clinical institutions across Taiwan and Asia, it refines products based on clinical feedback. ISO 13485-certified, A Plus owns several patents and serves customers worldwide, prioritising precision and innovation in surgical automation. Its PSI systems combine clinical imaging with digital modelling to shorten surgery time and reduce complications in advanced procedures.